Predictors of Septic Shock or Bacteremia in Children Experiencing Febrile Neutropenia Post-Chemotherapy
- PMID: 35924573
- PMCID: PMC9720364
- DOI: 10.1093/jpids/piac080
Predictors of Septic Shock or Bacteremia in Children Experiencing Febrile Neutropenia Post-Chemotherapy
Abstract
Background: Febrile neutropenia (FN) is an early indicator of infection in oncology patients post-chemotherapy. We aimed to determine clinical predictors of septic shock and/or bacteremia in pediatric cancer patients experiencing FN and to create a model that classifies patients as low-risk for these outcomes.
Methods: This is a retrospective analysis with clinical data of a cohort of pediatric oncology patients admitted during July 2015 to September 2017 with FN. One FN episode per patient was randomly selected. Statistical analyses include distribution analysis, hypothesis testing, and multivariate logistic regression to determine clinical feature association with outcomes.
Results: A total of 865 episodes of FN occurred in 429 subjects. In the 404 sampled episodes that were analyzed, 20.8% experienced outcomes of septic shock and/or bacteremia. Gram-negative bacteria count for 70% of bacteremias. Features with statistically significant influence in predicting these outcomes were hematological malignancy (P < .001), cancer relapse (P = .011), platelet count (P = .004), and age (P = .023). The multivariate logistic regression model achieves AUROC = 0.66 (95% CI 0.56-0.76). The optimal classification threshold achieves sensitivity = 0.96, specificity = 0.33, PPV = 0.40, and NPV = 0.95.
Conclusions: This model, based on simple clinical variables, can be used to identify patients at low-risk of septic shock and/or bacteremia. The model's NPV of 95% satisfies the priority to avoid discharging patients at high-risk for adverse infection outcomes. The model will require further validation on a prospective population.
Keywords: cancer; children; clinical decision rule; febrile neutropenia; risk prediction.
© The Author(s) 2022. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society.
Figures

Similar articles
-
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.Front Cell Infect Microbiol. 2015 Feb 12;5:11. doi: 10.3389/fcimb.2015.00011. eCollection 2015. Front Cell Infect Microbiol. 2015. PMID: 25729741 Free PMC article.
-
A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.Sci Rep. 2022 May 6;12(1):7429. doi: 10.1038/s41598-022-11576-z. Sci Rep. 2022. PMID: 35523855 Free PMC article.
-
Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia.Intern Emerg Med. 2019 Apr;14(3):433-440. doi: 10.1007/s11739-018-02015-x. Epub 2019 Jan 1. Intern Emerg Med. 2019. PMID: 30600529
-
Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.J Pediatr Hematol Oncol. 2020 Aug;42(6):e445-e451. doi: 10.1097/MPH.0000000000001814. J Pediatr Hematol Oncol. 2020. PMID: 32404688
-
Shock and Early Death in Hematologic Patients with Febrile Neutropenia.Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01250-19. doi: 10.1128/AAC.01250-19. Print 2019 Nov. Antimicrob Agents Chemother. 2019. PMID: 31405857 Free PMC article. Review.
Cited by
-
A scoping review on pediatric sepsis prediction technologies in healthcare.NPJ Digit Med. 2024 Dec 4;7(1):353. doi: 10.1038/s41746-024-01361-9. NPJ Digit Med. 2024. PMID: 39633080 Free PMC article.
-
Fever in Children with Cancer: Pathophysiological Insights Using Blood Transcriptomics.Int J Mol Sci. 2025 Jul 24;26(15):7126. doi: 10.3390/ijms26157126. Int J Mol Sci. 2025. PMID: 40806258 Free PMC article.
-
Economic implications of step-down outpatient management for fever and neutropenia episodes in pediatric cancer patients: a cost minimization analysis.BMC Health Serv Res. 2024 Aug 24;24(1):981. doi: 10.1186/s12913-024-11442-w. BMC Health Serv Res. 2024. PMID: 39182090 Free PMC article.
-
Cathelicidin, but not vitamin D, is associated independently with sepsis in pediatric patients with cancer and febrile neutropenia.Mol Clin Oncol. 2024 Dec 19;22(2):22. doi: 10.3892/mco.2024.2817. eCollection 2025 Feb. Mol Clin Oncol. 2024. PMID: 39776942 Free PMC article.
References
-
- Lehrnbecher T, Robinson P, Fisher B, et al. . Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol 2017; 35:2082–94. - PubMed
-
- Avilés-Robles MJ, Reyes-López A, Otero-Mendoza FJ, et al. . Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: a noninferiority multicenter randomized clinical trial. Pediatr Blood Cancer 2020; 67:e28251. doi:10.1002/pbc.28251 - DOI - PubMed
-
- Santolaya ME, Alvarez AM, Aviles CL, et al. . Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol 2004; 22:3784–9. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous